Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | |
| Operating Expenses | 6,710 | 4,662 |
| Operating Income | -6,710 | -4,662 |
| Interest Expense | 13 | 12 |
| Other Income | 94 | 116 |
| Pre-tax Income | -6,629 | -4,558 |
| Net Income Continuous | -7,155 | -4,893 |
| Net Income | $-7,155 | $-4,893 |
| EPS Basic Total Ops | -0.32 | -1.85 |
| EPS Basic Continuous Ops | -0.32 | -1.85 |
| EPS Diluted Total Ops | -0.32 | -1.85 |
| EPS Diluted Continuous Ops | -0.32 | -1.85 |
| EBITDA(a) | $-6,695 | $-4,662 |